BEAM
27.61 USD
+3.57%
Today
+4.20%
1D
Market is closed
Sun
Closed
Mon
4:30 PM ~ 11:00 PM
Tue
4:30 PM ~ 11:00 PM
Wed
4:30 PM ~ 11:00 PM
Thu
4:30 PM ~ 11:00 PM
Fri
4:30 PM ~ 11:00 PM
Sat
Closed
Information
Name
Beam Therapeutics Leveraged
Currency
USD
Standard Leverage
1X
Enhanced Leverage
3X
Overnight Fees Buy
-0.0191%
Overnight Fees Sell
0.0024%
Market Cap
2.44B
Avg Daily Volume
1.73M
52 Week High
36.44 USD
52 Week Low
13.525 USD
Trading Hours
See hours
Overnight Fees Calculator
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01910% | $(0.191) |
| SELLS | 0.00240% | $0.024 |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
Business Summary
Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. Its programs in hematology and genetic disease portfolio include Ristoglogene autogetemcel, a patient-specific, autologous hematopoietic stem cell (HSC) therapy for the treatment of sickle cell disease; BEAM-302, a liver-targeting lipid nanoparticle (LNP) for the treatment of severe alpha-1 antitrypsin deficiency; BEAM-304, a liver-targeting LNP for the treatment of phenylketonuria; and BEAM-301, a liver-targeting LNP formulation for the treatment of glycogen storage disease type 1a. The company also develops the ESCAPE platform, which combines antibody-based conditioning with multiplex gene edited HSCs. In addition, it develops BEAM-103, an anti-CD117 monoclonal antibody that enables ESCAPE. The company has research collaboration agreement with Pfizer Inc., focusing on in vivo base editing programs for targets rare genetic diseases of the liver, muscle, and central nervous system; Verve Therapeutics, Inc., for cardiovascular disease treatments; and Orbital Therapeutics to design RNA for the prevention, treatment, or diagnosis of human disease. Beam Therapeutics Inc. was incorporated in 2017 and is based in Cambridge, Massachusetts.
Top News
Beam Therapeutics Announces Publication of BEACON Phase 1/2 Data for risto-cel in Patients with Sickle Cell Disease (SCD) in The New England Journal of Medicine
tradingview.com
1w ago
ADMA.Biologics
-3.12%
Alexandria
-3.37%
AST.SpaceMobile
+2.78%
Anavex
-3.96%
Beam_Therapeutics
+4.20%
Bunge
+0.71%
BWX_Tech
-0.43%
BostonProp
+1.07%
Chewy
-2.86%
Corcept
-0.85%
Cintas
+0.43%
Chevron
-0.53%
Draftkings.inc
-0.04%
DigitalOcean
-13.30%
Devon
+0.23%
Figma
-4.58%
Generac
+0.23%
GoPro
+4.23%
Honeywell
-0.45%
JetBlue
-3.88%
JPMorgan
+0.09%
KB_Home
-1.15%
Kilroy
+1.48%
Liberty.Energy
+1.10%
LockheedM
-1.76%
MarathonP
+0.07%
MicronTech
-0.08%
NewmontM
+2.35%
NatOilwell
-0.46%
Occidental
+0.00%
PaychexInc
-2.76%
Pinduoduo-Inc
-0.08%
Phillips66
-0.53%
Rocket-Lab
+1.31%
SLGreen
+0.95%
SanDisk.Corp
+0.16%
Sarepta
-4.83%
Tempus.AI
-2.73%
Terns.Pharma
+0.06%
10X_Genomics
+1.53%
Valero
+1.57%
Vornado
+1.42%
WesternDig
+1.64%
ExxonMobil
-1.24%
BUZZ-U.S. STOCKS ON THE MOVE-ADMA Biologics, Nanobiotix, DraftKings
reuters.com
2w ago
ADMA.Biologics
-3.12%
Alexandria
-3.37%
AST.SpaceMobile
+2.78%
Anavex
-3.96%
Beam_Therapeutics
+4.20%
Bunge
+0.71%
BWX_Tech
-0.43%
BostonProp
+1.07%
Chewy
-2.86%
Cintas
+0.43%
Chevron
-0.53%
Draftkings.inc
-0.04%
DigitalOcean
-13.30%
Devon
+0.23%
Figma
-4.58%
Generac
+0.23%
GoPro
+4.23%
Honeywell
-0.45%
JPMorgan
+0.09%
KB_Home
-1.15%
Kilroy
+1.48%
Liberty.Energy
+1.10%
LockheedM
-1.76%
MarathonP
+0.07%
MicronTech
-0.08%
NewmontM
+2.35%
Occidental
+0.00%
PaychexInc
-2.76%
Pinduoduo-Inc
-0.08%
Phillips66
-0.53%
Rocket-Lab
+1.31%
SLGreen
+0.95%
SanDisk.Corp
+0.16%
Sarepta
-4.83%
Tempus.AI
-2.73%
Terns.Pharma
+0.06%
10X_Genomics
+1.53%
Valero
+1.57%
Vornado
+1.42%
WesternDig
+1.64%
ExxonMobil
-1.24%
BUZZ-U.S. STOCKS ON THE MOVE-BWX, Generac, Cintas
reuters.com
2w ago
Show more
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
